APYX vs. SNWV, NYXH, ZIMV, SMTI, STIM, CATX, TCMD, NVRO, SGHT, and DRTS
Should you be buying Apyx Medical stock or one of its competitors? The main competitors of Apyx Medical include SANUWAVE Health (SNWV), Nyxoah (NYXH), ZimVie (ZIMV), Sanara MedTech (SMTI), Neuronetics (STIM), Perspective Therapeutics (CATX), Tactile Systems Technology (TCMD), Nevro (NVRO), Sight Sciences (SGHT), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.
Apyx Medical vs. Its Competitors
Apyx Medical (NASDAQ:APYX) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.
In the previous week, Apyx Medical had 2 more articles in the media than Sanuwave Health. MarketBeat recorded 2 mentions for Apyx Medical and 0 mentions for Sanuwave Health. Apyx Medical's average media sentiment score of 1.44 beat Sanuwave Health's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media.
Apyx Medical has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Sanuwave Health has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.
Apyx Medical has a net margin of -42.37% compared to Sanuwave Health's net margin of -89.86%. Sanuwave Health's return on equity of 0.00% beat Apyx Medical's return on equity.
Apyx Medical received 78 more outperform votes than Sanuwave Health when rated by MarketBeat users. Likewise, 60.94% of users gave Apyx Medical an outperform vote while only 0.00% of users gave Sanuwave Health an outperform vote.
55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 16.8% of Apyx Medical shares are owned by company insiders. Comparatively, 36.6% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Apyx Medical has higher revenue and earnings than Sanuwave Health. Sanuwave Health is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Apyx Medical beats Sanuwave Health on 14 of the 17 factors compared between the two stocks.
Get Apyx Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Apyx Medical Competitors List
Related Companies and Tools
This page (NASDAQ:APYX) was last updated on 6/23/2025 by MarketBeat.com Staff